Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rh2(S PTAD)4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113087714B reveals a novel Rh(II)-catalyzed N-H insertion route for axial chiral indolocarbazoles, offering high enantioselectivity and scalable pharmaceutical intermediate manufacturing.
Patent CN113087714B discloses a novel Rh(II)-catalyzed N-H insertion method for axial chiral aryl indole carbazoles, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.